Last Updated: 08 Nov 2024
Executive Summary
SMX (Security Matters) Public Limited Company Class A Ordinary Shares (Symbol: SMX) is a technology company engaged in developing and commercializing track and trace technologies. Despite its small market capitalization of $856.42 million, SMX has a high trailing price-to-book ratio of 0.0877, indicating potential undervaluation. However, its negative EBITDA of -$14.27 million and lack of revenue raise concerns about its financial performance.
Company Overview
SMX is headquartered in Melbourne, Australia, and operates in the MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT industry. The company focuses on providing track and trace solutions for various industries.
Fundamental Analysis
Earnings: SMX reported diluted EPS of $832.81 for the latest quarter ended September 30, 2023.
Revenue: The company's revenue for the trailing twelve months (TTM) is $0, indicating a lack of recent revenue generation.
Profitability: SMX has negative profit margins, including a gross profit margin of 0% and an operating margin of 0%.
Return on Assets: The company's return on assets (ROA) TTM is -0.297, indicating a negative return on its assets.
Return on Equity: SMX's return on equity (ROE) TTM is 0.123, suggesting a positive return on its shareholders' equity.
Technical Analysis
Moving Averages: SMX's 50-day moving average is $2.461, while its 200-day moving average is $9.51. The current price of $0.31 is well below both moving averages, indicating a bearish trend.
Beta: The company's beta of -1.931 suggests a high volatility compared to the overall market.
Short Term Outlook
Based on the technical analysis, SMX's short-term outlook appears bearish. The stock price is significantly below its moving averages, and the beta indicates high volatility.
Long Term Outlook
The company's lack of revenue and negative profitability raise concerns about its long-term viability. SMX needs to demonstrate significant improvement in its financial performance to attract investors.
Analyst Recommendations
No analyst recommendations are currently available for SMX.
